HOME >> BIOLOGY >> NEWS
Women's health findings presented at national conference

The clinical and basic science research findings of more than a dozen studies are being presented by researchers from the University of Pittsburgh-affiliated Magee-Womens Research Institute (MWRI) at the 53rd annual meeting of the Society for Gynecologic Investigation. In addition, a major conference debate on the essence of preeclampsia will feature James Roberts, M.D., MWRI director. Scientific sessions will take place March 22 to 25 at the Westin Harbour Castle in Toronto.

An internationally known authority, Dr. Roberts will argue that preeclampsia is a maternal disease. Christopher Redman, M.D., of the University of Oxford, England, will take a contrary position, arguing that preeclampsia is a fetal disease.

"It's a way to present the state-of-the-art in preeclampsia research," said Dr. Roberts, professor and vice chairman of research in the department of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh School of Medicine. "But the impact goes beyond pregnancy because the risks for preeclampsia are the same as those for cardiovascular disease later in life."

Some 5 percent of first pregnancies are complicated by preeclampsia, a condition characterized by soaring blood pressure and protein in the urine, that is a leading cause of maternal, fetal and neonatal disability and death, particularly in undeveloped countries and among underserved populations.

The preeclampsia debate is scheduled for 2 p.m. ET Thursday, March 23.

Among other findings being presented are:

Heart disease biomarker remains elevated even 30 years after eclamptic pregnancy

C-reactive protein (CRP), an inflammatory marker associated with a higher risk of cardiovascular disease, remains elevated even 30 years after a pregnancy distinguished by eclampsia, according to a study from MWRI. A life-threatening complication of pregnancy, eclampsia occasionally succeeds preeclampsia and can involve coma, convul
'"/>


25-Mar-2006


Page: 1 2 3 4

Related biology news :

1. Brandeis and Brigham and Womens Hospital license technology for Gauchers to Amicus Therapeutics
2. Womens skin tone influences perception of beauty, health and age
3. Womens math performance affected by theories on sex differences: UBC researchers
4. Womens Bioethics Project unveils The Scientist & the Ethicist podcast series
5. Womens bioethics project receives grant from Ford Foundation
6. 2006 SGO Annual Meeting on Womens Cancer
7. Womens health study finds vitamin E does not protect women from heart attack, stroke, or cancer
8. Womens health, tissue regeneration is focus of Illinois & Carle Hospital initiative
9. Particle emissions from laser printers might pose health concern
10. Cell damage caused by brushing may help keep gums healthy
11. New studies on goats milk show it is more beneficial to health than cows milk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2020)... ... April 27, 2020 , ... ... service was started by three teenagers with an idea to help millions of ... during the time of great need and suffering, an outlet has been created ...
(Date:4/22/2020)... ... April 21, 2020 , ... Captis ... venture capital firm that provides patent development support for early stage startups. The ... illnesses such as ovarian cancer and precancerous pancreatic lesions with simple, accurate and ...
(Date:4/16/2020)... ... April 15, 2020 , ... With the exploding ... a vaccine to this novel virus. In an effort to accelerate breakthroughs, including ... (LRC), is announcing the development of Sample.Exchange, a web-based platform that will ...
Breaking Biology News(10 mins):
(Date:5/1/2020)... , ... April 30, 2020 , ... ... announced today, honoring the businesses, policies, projects, and concepts that are actively engaged ... bioprinter for living cells, which has taken out the top prize in the ...
(Date:4/22/2020)... Mass. (PRWEB) , ... April 20, 2020 , ... ... US offices in Cambridge, MA, announced today that Omixon’s founder and chairman Dr. ... commercialisation of Omixon’s flagship product Holotype HLA since 2014 before stepping into the ...
(Date:4/18/2020)... ... , ... NeuroFlow has been awarded $750,000 from ... the expansion of its digital health platform enabling behavioral health integration in all ... process, adds to NeuroFlow’s recent government awards . , The SBIR Phase ...
(Date:4/1/2020)... Ky. (PRWEB) , ... March 30, 2020 , ... ... launch of its latest product, ArmourGuard® RTU, an EPA-approved spray-on antimicrobial solution. As ... only biosecurity solution that provides continual antimicrobial activity against microorganisms for up to ...
Breaking Biology Technology:
Cached News: